Page last updated: 2024-11-05

tolbutamide and Multiple Myeloma

tolbutamide has been researched along with Multiple Myeloma in 2 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Howbert, JJ1
Grossman, CS1
Crowell, TA1
Rieder, BJ1
Harper, RW1
Kramer, KE1
Tao, EV1
Aikins, J1
Poore, GA1
Rinzel, SM1
Heffernan, AG1

Other Studies

2 other studies available for tolbutamide and Multiple Myeloma

ArticleYear
Novel agents effective against solid tumors: the diarylsulfonylureas. Synthesis, activities, and analysis of quantitative structure-activity relationships.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:9

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Humans; Lymphoma, Non

1990
Unusual presentation of multiple myeloma.
    Postgraduate medical journal, 1972, Volume: 48, Issue:559

    Topics: Female; Humans; Hypoglycemia; Middle Aged; Multiple Myeloma; Tolbutamide

1972